SCHEMBL1688847

SCHEMBL1688847

Cc1cccc2c1C(=O)c1cccc(C)c1C2=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
MAPK1 P28482 3/20 0.55
L3MBTL1 Q9Y468 3/20 0.55
RAB9A P51151 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
NPC1 O15118 1/20 0.55
CYP3A4 P08684 1/20 0.55
TSHR P16473 1/20 0.55
CASP3 P42574 1/20 0.55
HBB P68871 1/20 0.55
SENP7 Q9BQF6 1/20 0.55
SENP6 Q9GZR1 1/20 0.55
MAOA P21397 2/20 0.52
ADORA2A P29274 2/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA7 P43166 1/20 0.52
CA9 Q16790 1/20 0.52
ELANE P08246 2/20 0.50
USP8 P40818 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL224650 0.93 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL30580334 0.93 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL12258322 0.92 ALDH1A1 (0.54) ALDH1A1MAPK1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL4019686 0.90 ALDH1A1 (0.55) ALDH1A1MAPK1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL4161497 0.90 CA1 (0.52) ALDH1A1MAPK1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL6036681 0.90 TDP2 (0.52) ALDH1A1MAPK1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL29634210 0.90 CA1 (0.52) ALDH1A1MAPK1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL5585492 0.89 ADORA2A (0.70) ALDH1A1MAPK1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL11404062 0.89 ALDH1A1 (0.47) ALDH1A1MAPK1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL3976848 0.88 SMN1; SMN2 (0.55) ALDH1A1MAPK1L3MBTL1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240019738-A1 DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF JAPAN DISPLAY INC. (JP) 2024-01-18 US disclosed
US-20240019738-A1 DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF JAPAN DISPLAY INC. (JP) 2024-01-18 US disclosed
US-11112654-B2 Liquid crystal display device NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2021-09-07 US disclosed
US-11028323-B2 Liquid crystal aligning agent containing crosslinking agent and polymer that has site having isocyanate group and/or blocked isocyanate group and site having photoreactivity, liquid crystal alignment film, and liquid crystal display element NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2021-06-08 US disclosed
US-10921650-B2 Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2021-02-16 US disclosed
US-20200347226-A1 RESIN COMPOSITION FOR INSULATING FILM NISSAN CHEMICAL CORPORATION (JP) 2020-11-05 US disclosed
US-10761375-B2 Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2020-09-01 US disclosed
US-10573834-B2 Coating liquid for gate insulating film, gate insulating film and organic transistor NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2020-02-25 US disclosed
WO-2019189416-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2019-10-03 WO disclosed
WO-2019189632-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2019-10-03 WO disclosed
EP-1857521-A1 ORGANIC ELECTRIC FIELD LIGHT EMITTING ELEMENT AND PRODUCTION THEREFOR Mitsubishi Chemical Corporation (JP) 2007-11-21 EP disclosed
US-7258918-B2 Method for connecting electrodes, surface-treated wiring board and adhesive film used in the method, and electrode-connected structure HITACHI CHEMICAL CO., LTD. (JP) 2007-08-21 US disclosed
US-7258918-B2 Method for connecting electrodes, surface-treated wiring board and adhesive film used in the method, and electrode-connected structure HITACHI CHEMICAL CO., LTD. (JP) 2007-08-21 US disclosed
WO-2007090864-A1 PROCESS FOR PREPARING POROUS ORGANIC FRAMEWORK MATERIALS BASF SE (DE) 2007-08-16 WO disclosed
US-20070148493-A1 Organic electroluminescence device FUJI XEROX CO., LTD. 2007-06-28 US disclosed
US-20070148493-A1 Organic electroluminescence device FUJI XEROX CO., LTD. 2007-06-28 US disclosed
WO-2007057391-A1 ORGANOMETALLIC FRAMEWORK MATERIALS OF TRANSITION GROUP III BASF SE (DE) 2007-05-24 WO disclosed
US-20070066724-A1 Bisazoquinolone pigments, processes for their preparation and their use BENKHOFF JOHANNES 2007-03-22 US disclosed
US-20070066724-A1 Bisazoquinolone pigments, processes for their preparation and their use BENKHOFF JOHANNES 2007-03-22 US disclosed
WO-2007023134-A1 METHOD FOR PRODUCING ORGANOMETALLIC FRAMEWORK MATERIALS CONTAINING MAIN GROUP METAL IONS BASF AKTIENGESELLSCHAFT (DE) 2007-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066724-A1 Bisazoquinolone pigments, processes for their preparation and their use NR2E3, NR4A3, NR4A1 ALDH1A1 3399/4885MAPK1 3276/4885L3MBTL1 1630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.